REDS.ST Redsense Medical AB
- Market cap
- SEK 56.4M
- P/E
- -
- P/B
- 1.65x
- ROE
- 8.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is REDS.ST undervalued?
Graham numberThe Graham number of Redsense Medical AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Redsense Medical AB fundamental analysis
No fundamental analysis for Redsense Medical AB yet.
Redsense Medical AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Redsense Medical AB
Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.
Full company profileRedsense Medical AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Redsense Medical AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | 14.4M | 9.36M | 14.3M | 25.0M | 28.2M | 24.0M | 27.0M |
| Gross Profit | - | 9.96M | 10.4M | 11.3M | 13.1M | 18.1M | 15.6M | 19.6M |
| Operating Income | - | -8.12M | -12.0M | -10.2M | -5.07M | 209K | -7.37M | 2.91M |
| EBITDA | - | - | - | -8.60M | -4.42M | 444K | -6.50M | 4.33M |
| Net Income | - | -9.03M | -7.97M | -8.76M | -4.51M | 342K | -7.17M | 3.08M |
| EPS | - | -0.64 | -0.57 | -0.62 | -0.32 | 0.02 | -0.44 | 0.19 |
| Balance Sheet | ||||||||
| Total Assets | - | 78.7M | 43.3M | 30.7M | 26.5M | 41.8M | 39.3M | 38.6M |
| Total Liabilities | - | 5.51M | 5.76M | 3.58M | 3.41M | 2.21M | 4.98M | 3.03M |
| Shareholders' Equity | - | 73.2M | 37.5M | 27.1M | 23.1M | 39.6M | 34.3M | 35.6M |
| Cash & Short-term Investments | - | 29.0M | 4.98M | 3.67M | 6.97M | 15.4M | 7.36M | 4.62M |
| Cash Flow | ||||||||
| Operating Cash Flow | - | 17.2M | -12.2M | -9.78M | -5.05M | -8.23M | -5.20M | -4.71M |
| Capital Expenditure | 0.00 | 37.1M | 9.22M | 2.46M | 603K | 611K | 2.81M | 778K |
| Free Cash Flow | - | -19.8M | -21.4M | -12.2M | -5.66M | -8.84M | -8.01M | -5.48M |
| Ratios | ||||||||
| ROE | - | -12.3% | -21.3% | -32.3% | -19.5% | 0.9% | -20.9% | 8.7% |
| ROA | - | -11.5% | -18.4% | -28.5% | -17.0% | 0.8% | -18.3% | 8.0% |
| Net Profit Margin | - | -62.6% | -85.2% | -61.1% | -18.1% | 1.2% | -29.9% | 11.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Redsense Medical AB dividends
Redsense Medical AB has not paid dividends in the last 7 fiscal years.
Who owns Redsense Medical AB
- Insiders 42.92%
- Institutions 14.09%
- Public & others 42.99%
- Shares outstanding 16.4M
- Free float 7.77M
Redsense Medical AB company profile
- Company name
- Redsense Medical AB
- Ticker
- REDS.ST
- ISIN
- SE0006965158
- Exchange
- Stockholm Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 4
- Fiscal year end
- December
- Address
- Storgatan 36, Halmstad, Sweden, 302 43
- Phone
- 46 35 10 60 30
- Website
- redsensemedical.com
About Redsense Medical AB
Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.
Redsense Medical AB management
3- Mr. Sebastien BollueChief Executive Officer
- Mr. Peter LarssonChief Financial Officer · born 1969
- Ms. Ann-Marie ErikssonChief Technology Officer